Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:35 pm Sale |
2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB BIOTECH AG | 3,515,150 6.200% |
-484,850 (-12.12%) |
Filing History |
| 2025-02-04 12:02 pm Purchase |
2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FARALLON CAPITAL PARTNERS LP | 5,674,466 9.900% |
13,600 (+0.24%) |
Filing History |
| 2024-11-14 3:44 pm Sale |
2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 2,207,070 3.880% |
-1,316,930 (-37.37%) |
Filing History |
| 2024-11-08 2:40 pm Purchase |
2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FARALLON CAPITAL PARTNERS LP | 5,660,866 9.900% |
1,493,264 (+35.83%) |
Filing History |
| 2024-02-14 2:21 pm Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 3,524,000 6.310% |
774,000 (+28.15%) |
Filing History |
| 2024-02-14 2:06 pm Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Rock Springs Capital Management LP | 2,152,173 3.850% |
-844,419 (-28.18%) |
Filing History |
| 2024-02-13 06:07 am Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB BIOTECH AG | 4,000,000 7.200% |
-30,792 (-0.76%) |
Filing History |
| 2024-02-12 11:21 am Purchase |
2024-01-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
The Vanguard Group | 5,599,917 10.020% |
72,479 (+1.31%) |
Filing History |
| 2024-02-12 10:50 am Purchase |
2023-12-29 | 13G | Agios Pharmaceuticals, Inc. AGIO |
The Vanguard Group | 5,527,438 9.890% |
192,362 (+3.61%) |
Filing History |
| 2024-02-08 11:39 am Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FARALLON CAPITAL PARTNERS LP | 4,167,602 7.500% |
206,000 (+5.20%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
4,962,237 8.900% |
193,363 (+4.05%) |
Filing History |
| 2024-01-22 12:37 pm Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
STATE STREET CORP STT |
2,625,685 4.700% |
-553,383 (-17.41%) |
Filing History |
| 2023-11-09 5:18 pm Purchase |
2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
FARALLON CAPITAL PARTNERS LP | 3,961,602 7.100% |
3,961,602 (New Position) |
Filing History |
| 2023-11-09 1:26 pm Sale |
2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
WELLINGTON MANAGEMENT CO LLP | 2,200,757 3.950% |
-3,522,374 (-61.55%) |
Filing History |
| 2023-04-10 09:06 am Purchase |
2023-03-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
WELLINGTON MANAGEMENT CO LLP | 5,723,131 10.350% |
260,474 (+4.77%) |
Filing History |
| 2023-02-14 4:10 pm Sale |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB BIOTECH AG | 4,030,792 7.300% |
-281,500 (-6.53%) |
Filing History |
| 2023-02-14 2:50 pm Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Rock Springs Capital Management LP | 2,996,592 5.450% |
2,996,592 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
PRICE T ROWE ASSOCIATES INC | 1,480,194 2.700% |
-1,398,520 (-48.58%) |
Filing History |
| 2023-02-14 11:54 am Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 2,750,000 5.010% |
2,750,000 (New Position) |
Filing History |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
The Vanguard Group | 5,335,076 9.710% |
266,486 (+5.26%) |
Filing History |